Actuate Therapeutics Inc (ACTU) NASDAQ
1.82
-0.06(-3.19%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.82
-0.06(-3.19%)
Currency In USD
| Market Cap | 128.65M |
| Enterprise Value | 115.9M |
| P/E Ratio | -1.99 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 11.32 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.65 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.42 |
| Return On Equity | -4.31 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -22.5M |
| Net Income | -22.23M |
| Diluted EPS | -1.06 |
| Total Cash | 8.13M |
| Total Cash/Share | 0.35 |
| Total Debt | 404,991 |
| Total Debt/Equity | 0.11 |
| Current Ratio | 1.8 |
| Book Value Per Share | 0.16 |
| 52-Week Change | -80.02 |
| 52-Week High | 9.35 |
| 52-Week Low | 1.58 |
| Moving Average 50 Days | 2.48 |
| Moving Average 200 Days | 5.21 |
| Average Volume | 144,814 |
| Shares Outstanding | 23.93M |
| % Held by Institutions | 59.62 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |